Afecta negativamente a mltiples sistemas orgnicos e incrementa el riesgo de desarrollar otras patologas, como enfermedad cardiovascular, diabetes mellitus tipo 2, enfermedad del hgado graso no alcohlico, apnea obstructiva del sueo, artrosis, ansiedad, depresin e, incluso, algunos tipos de cncer
Moreover, improvements in insulin sensitivityachievable through GLP-1RAsmay mitigate pain-related symptoms, as insulin resistance has been implicated in chronic inflammation and heightened pain perception (75)
For these patients, being able to stop thinking about food is a relief, and can lead to an overall healthier lifestyle
Subjects with a broad variety of RI were enrolled in the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) program (the phase III development program for semaglutide)